As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...
ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...
Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...
The research has generated significant interest from firms in food & as consumers seek natural alternatives to GLP-1 drugs.
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...